$114.50
▼ -0.2% Today
as of Sep 4, 16:45 ET
Last 30 days
Recent Press Releases & News
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
ABIVAX Société Anonyme (ENXTPA:ABVX) Adds Commercial Leaders, Is The Upside Already Priced In?
Abivax (ENXTPA:ABVX) Adds Commercial Leaders And Signs Valerio R And D Deal
Overview
52-week range
$70
$149
57% of range
Avg surprise (last 3)
+7.9%
Avg reaction (last 2)
+1.9%
50% positive
Latest IV / EM
66%
EM ±12.6% · $115 · Sep 25
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 22, 2026 | Mar/2026 | $-0.71 | $-1.07 | +33.6% | +18.4% | -1.6% | earnings |
| Mon Sep 8, 2025 | Jun/2025 | $-0.86 | $-0.90 | +4.4% | — | — | earnings |
| Mon Jun 2, 2025 | Mar/2025 | $-0.87 | $-0.76 | -14.5% | — | +5.5% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Sep 21, 2026 | Jun/2026 | AMC | -$1.08 | -$0.86 | -25.6% |